0001821825-24-000033.txt : 20240402
0001821825-24-000033.hdr.sgml : 20240402
20240402162936
ACCESSION NUMBER: 0001821825-24-000033
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240329
FILED AS OF DATE: 20240402
DATE AS OF CHANGE: 20240402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ali Kevin
CENTRAL INDEX KEY: 0001859698
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40235
FILM NUMBER: 24814713
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Organon & Co.
CENTRAL INDEX KEY: 0001821825
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 464838035
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30 HUDSON STREET
STREET 2: FL 33
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302
BUSINESS PHONE: 551-430-6000
MAIL ADDRESS:
STREET 1: 30 HUDSON STREET
STREET 2: FL 33
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302
4
1
wk-form4_1712089757.xml
FORM 4
X0508
4
2024-03-29
0
0001821825
Organon & Co.
OGN
0001859698
Ali Kevin
C/O ORGANON & CO.
30 HUDSON STREET, FLOOR 33
JERSEY CITY
NJ
07032
1
1
0
0
Chief Executive Officer
0
Restricted Stock Units
2024-03-29
4
A
0
146276
0
A
2025-03-29
2027-03-29
Common Stock
146276
146276
D
Stock Option (right to buy)
18.80
2024-03-29
4
A
0
599128
0
A
2025-03-29
2027-03-29
Common Stock
599128
599128
D
The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.
These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.
The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Kevin Ali
2024-04-02